Allergan plc, a leading global pharmaceutical company, announced that it has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

New User Registration
* Please indicate that you agree to the Terms of Service
*Required field